Description
ENHANCED ANTIBACTERIAL ACTIVITY
CA increases Cefpodoxime acvity against
beta-lactamase producing pathogens
BROADER ZONE OF INHIBITION
CA improves Cefpodoxime ac vity against both
Gram+ve and Gram-ve microorganisms.
SYNERGISTIC KILL POWER
Results in early symptomatic relief.
INDICATIONS
ENT Infections
Uncomplicated U.T.I.
Upper & Lower R.T.I.
Uncomplicated Skin &
Soft Tissue Infections





Reviews
There are no reviews yet.